Chester County News and Community Website
WILMINGTON, DE — Incyte (Nasdaq: INCY) said the European Commission has approved Minjuvi (tafasitamab) in combination with lenalidomide and rituximab for adult patients with relapsed or refractory follicular lymphoma, introducing …
Europe Approves Incyte’s Dual-Target Lymphoma Therapy, Expanding Options Read More
WILMINGTON, DE — AstraZeneca PLC (NASDAQ: AZN) and Japan’s Daiichi Sankyo said the U.S. Food and Drug Administration has approved ENHERTU in combination with pertuzumab as a first-line treatment for …
FDA Clears ENHERTU Combo as First-Line Breakthrough in HER2 Breast Cancer Read More
WILMINGTON, DE — JPMorgan Chase & Co. (NYSE: JPM) said Chase Freedom and Freedom Flex cardmembers will be able to earn 5% cash back on select rotating categories during the …
Chase Dangles 5% Cash Back on Dining, Cruises, and Charity in 2026 Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) said Hervé Hoppenot recently resigned from its board of directors, effective immediately, formally ending a transition period that followed his long tenure as the …
Incyte Board Exit Closes an Era for the Biotech’s Longtime Leader Read More
WILMINGTON, DE — Global project finance is entering a period of rapid expansion and rising complexity as demand for energy capacity, digital infrastructure, and large-scale public works reshapes where capital …
Private Capital Rushes In as Project Finance Hits a Global Turning Point Read More
WILMINGTON, DE — Qnity Electronics, Inc. (NYSE: Q) is pairing shareholder returns with a leadership transition, announcing a quarterly cash dividend and naming a new interim head of its Semiconductor …
Qnity Signals Stability With Dividend as It Shakes Up Semiconductor Leadership Read More
WILMINGTON, DE — Cyber threat intelligence firm Intel 471 has promoted two senior leaders to its executive team, a move the company says is designed to accelerate revenue growth and …
Intel 471 Elevates Sales and Tech Leaders to Fuel Next Growth Push Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) reported strong early-stage clinical results for an experimental precision antibody that sharply reduced disease markers in patients with essential thrombocythemia, bolstering hopes for a …
Incyte’s Precision Antibody Delivers Striking Results in Rare Blood Cancer Read More
WILMINGTON, DE — Phreesia, Inc. (NYSE: PHR) reported a sharp financial turnaround in its fiscal third quarter, posting a return to profitability and stronger cash generation as revenue climbed and …
Phreesia Swings to Profit as Growth Accelerates and AccessOne Deal Lands Read More
WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW; OTC: ONFOP) said its board of directors has declared a regular quarterly dividend of $0.75 per share on the company’s Series …
Onfolio Declares Preferred Dividend, Extending Five-Year Payout Streak Read More